This inventor holds 3 USPTO granted patents and 2 published patent applications. Top assignees: Boehringer Ingelheim International Gmbh, Santen Pharmaceutical Co., Ltd.. Active years: 2022-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
3 out of 1,562 
3 out of 282 
Years Active: 2022-2026
Title: Nagayoshi Asano - Innovator in Medicinal Chemistry
Introduction
Nagayoshi Asano is an inventor based in Ikoma-shi, Nara, Japan. He has made significant contributions to the field of medicinal chemistry, particularly in the development of treatments for dry eye conditions. His innovative approach focuses on compounds that do not substantially impact intraocular pressure, which is crucial for patient safety and comfort.
Latest Patent Applications
Asano's notable patent application is titled "MEDICAMENT FOR PREVENTING AND/OR TREATING DRY EYE." This application describes a compound useful for preventing or treating dry eye, specifically comprising olodaterol or a salt thereof as an active ingredient. The invention aims to provide an effective medicament that addresses the symptoms of dry eye without adversely affecting intraocular pressure.
Conclusion
Nagayoshi Asano's work in developing treatments for dry eye showcases his commitment to advancing medicinal chemistry. His innovative applications have the potential to improve the quality of life for individuals suffering from this condition.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile